ANDA 88268, held by Chartwell Rx. Diethylpropion Hydrochloride.
As of Nov 16, 2026, ANDA 88268 (Diethylpropion Hydrochloride), held by Chartwell Rx, was first approved by FDA on Aug 25, 1983, with 9 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 25, 1983 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Diethylpropion Hydrochloride25MG ยท tablet;oral | Diethylpropion Hydrochloride | Discontinued |
| Oct 6, 2000 | Supplement 16Manufacturing | Approved | None posted |
| Jan 31, 1991 | Supplement 11Labeling | Approved | None posted |
| May 1, 1989 | Supplement 10Labeling | Approved | None posted |
| Apr 20, 1989 | Supplement 7Manufacturing | Approved | None posted |
| Feb 1, 1989 | Supplement 8Labeling | Approved | None posted |
| Apr 27, 1988 | Supplement 6Manufacturing | Approved | None posted |
| Dec 16, 1983 | Supplement 2Manufacturing | Approved | None posted |
| Dec 16, 1983 | Supplement 3Manufacturing | Approved | None posted |
| Nov 29, 1983 | Supplement 1Manufacturing | Approved | None posted |
| Aug 25, 1983 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters